Topics

Teva’s Generic Version of EpiPen Now Available in the United States

08:00 EST 29 Nov 2018 | Pharmaceutical Processing

Limited doses of the FDA-approved generic version of EpiPen will be available at a Wholesale Acquisition Cost of $300.
Contributed Author: 
Teva Pharmaceutical Industries
Topics: 

Original Article: Teva’s Generic Version of EpiPen Now Available in the United States

NEXT ARTICLE

More From BioPortfolio on "Teva’s Generic Version of EpiPen Now Available in the United States"

Quick Search